Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Safer JD, Coleman E, Feldman J et al (2016) Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes 23(2):168–171
2. UCSF Gender Affirming Health Program, Department of Family and Community Medicine, University of California San Francisco (2016) Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. In: Deutsch MB (ed) 2nd edition. Available at transcare.ucsf.edu/guidelines
3. Hembree WC, Cohen-Kettenis PT, Gooren L et al (2017) Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 102(11):3869–3903
4. Connelly PJ, Freel EM, Perry C et al (2019) Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults. Hypertension 74(6):1266–1274
5. American Psychiatric Association (2013) DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5; American Psychiatric Association: Washington, DC, USA